- Omalizumab2008 | Publication without faculty affiliation
- Mezioborová spolupráce při léčbě karcinomu močového měchýře2018 | Second Faculty of Medicine
- Xolair (anti IgE antibodies) - a promissing approach to treat severe form of bronchial asthma +12007 | Publication without faculty affiliation
- Pembrolizumab v první linii léčby nemalobuněčného karcinomu plic2018 | Second Faculty of Medicine
- Eculizumab - treatment of paroxysmal nocturnal hemoglobinuria.2012 | First Faculty of Medicine
- Subcutaneous tocilizumab in the treatment of rheumatoid arthritis2014 | First Faculty of Medicine
- Pembrolizumab - indication overview2019 | First Faculty of Medicine, Faculty of Physical Education and Sport
- 2020 AAN Highlights Long-term data on efficacy of CD20+depletion B-cells in the treatment of MS2020 | First Faculty of Medicine
- Influence of tocilizumab treatment on depression symptoms in patients with rheumatoid arthritis2015 | First Faculty of Medicine
- Use of tocilizumab in subcutaneous form for the treatment of rheumatoid arthritis2015 | Third Faculty of Medicine
- Indication Avastin in Ophthalmology2010 | Faculty of Medicine in Hradec Králové
- Ranibizumab (Lucentis) in the Treatmnet of Age-Related Macular Degeneration +12009 | Faculty of Medicine in Hradec Králové
- Mepolizumab in the treatment of pulmonary eosinophilias2017 | First Faculty of Medicine
- Ranibizumab (Lucentis) in the Treatmnet of Age-Related Macular Degeneration2009 | First Faculty of Medicine
- Alemtuzumab in the therapy of patients with relapsing-remitting multiple sclerosis2016 | First Faculty of Medicine
- Sacituzumab govitecan2022 | First Faculty of Medicine
- Atezolizumab2018 | First Faculty of Medicine, Faculty of Physical Education and Sport
- First-line pembrolizumab for metastatic non-small-cell lung cancer2020 | First Faculty of Medicine
- Pharmacological profile of mepolizumab2023 | Third Faculty of Medicine
- Subcutaneously delivered natalizumab for the treatment of highly active relapsing-remitting multiple sclerosis2022 | Faculty of Medicine in Hradec Králové
- Indications of ranibizumab in ophthalmology2012 | Faculty of Medicine in Hradec Králové
- Efficiency of bevacizumab in treatment for relapsing ovarian cancer: case report2013 | First Faculty of Medicine
- Inhibice interleukinu 6 - moderní léčba obrovskobuněčné arteriitidy2017 | First Faculty of Medicine
- Atezolizumab in the first-line treatment of non-small cell lung cancer - the IMpower110 trial2022 | First Faculty of Medicine
- Ixekizumab - a new first-line drug of biological therapy for psoriasis2018 | Second Faculty of Medicine
- Treatment persistence to ocrelizumab and local experience2021 | Faculty of Medicine in Hradec Králové
- Clinical experience with alemtuzuma2016 | Second Faculty of Medicine
- Alemtuzumab treatment in multiple slerosis: real clinical experience2019 | Faculty of Medicine in Hradec Králové